FdaApplication
NDA 215712
Identifiers
- fda_app_no: NDA215712
Properties
| Property | Value |
|---|---|
| applicant_name | PERRIGO PHARMA INTERNATIONAL DAC |
| application_type | NDA |
| approval_date | 2022-03-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NASONEX 24HR ALLERGY | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED;NASAL |
1 product